Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Practice Guidelines as Topic | 20 | 2024 | 1034 | 5.110 |
Why?
|
Evidence-Based Medicine | 4 | 2021 | 429 | 1.430 |
Why?
|
Hypoglycemia | 1 | 2024 | 107 | 0.920 |
Why?
|
Non-alcoholic Fatty Liver Disease | 3 | 2024 | 212 | 0.900 |
Why?
|
Ambulatory Care | 1 | 2024 | 181 | 0.880 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 806 | 0.870 |
Why?
|
Ferritins | 1 | 2021 | 29 | 0.820 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2021 | 19 | 0.820 |
Why?
|
Humans | 61 | 2024 | 86601 | 0.780 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 91 | 0.760 |
Why?
|
Macrolides | 1 | 2020 | 31 | 0.740 |
Why?
|
Fluoroquinolones | 1 | 2020 | 22 | 0.740 |
Why?
|
beta-Lactams | 1 | 2020 | 14 | 0.740 |
Why?
|
Smoking Cessation | 3 | 2016 | 230 | 0.730 |
Why?
|
Smoking Prevention | 2 | 2016 | 43 | 0.730 |
Why?
|
Lubricants | 1 | 2019 | 7 | 0.730 |
Why?
|
Laxatives | 1 | 2019 | 13 | 0.720 |
Why?
|
Testosterone | 2 | 2018 | 271 | 0.710 |
Why?
|
Menorrhagia | 1 | 2020 | 24 | 0.700 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2018 | 1373 | 0.670 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2018 | 18 | 0.650 |
Why?
|
Hair Removal | 1 | 2018 | 14 | 0.650 |
Why?
|
Pneumonia | 1 | 2020 | 179 | 0.650 |
Why?
|
Incidental Findings | 1 | 2018 | 95 | 0.640 |
Why?
|
Hirsutism | 1 | 2018 | 61 | 0.640 |
Why?
|
Algorithms | 2 | 2017 | 1830 | 0.640 |
Why?
|
Hypogonadism | 1 | 2018 | 37 | 0.630 |
Why?
|
Gender Dysphoria | 1 | 2017 | 6 | 0.630 |
Why?
|
Mass Screening | 4 | 2015 | 617 | 0.620 |
Why?
|
Aftercare | 1 | 2018 | 85 | 0.620 |
Why?
|
Gonadal Steroid Hormones | 1 | 2017 | 50 | 0.620 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 138 | 0.610 |
Why?
|
Physician-Patient Relations | 4 | 2020 | 610 | 0.610 |
Why?
|
Stroke Rehabilitation | 1 | 2018 | 41 | 0.610 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2017 | 28 | 0.600 |
Why?
|
Travel | 1 | 2017 | 68 | 0.600 |
Why?
|
Androgen Antagonists | 1 | 2018 | 144 | 0.600 |
Why?
|
Organizations | 1 | 2017 | 17 | 0.600 |
Why?
|
Guidelines as Topic | 1 | 2018 | 162 | 0.580 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 2600 | 0.570 |
Why?
|
Papillomavirus Infections | 2 | 2021 | 239 | 0.570 |
Why?
|
Diarrhea | 1 | 2017 | 182 | 0.570 |
Why?
|
Thyroid Nodule | 1 | 2017 | 51 | 0.570 |
Why?
|
Shock, Septic | 1 | 2017 | 102 | 0.550 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 378 | 0.550 |
Why?
|
Behavior Therapy | 1 | 2016 | 75 | 0.540 |
Why?
|
Health Services for the Aged | 1 | 2015 | 27 | 0.540 |
Why?
|
Hepatitis C Antibodies | 1 | 2015 | 8 | 0.540 |
Why?
|
Early Detection of Cancer | 2 | 2021 | 392 | 0.540 |
Why?
|
Papillomavirus Vaccines | 2 | 2021 | 58 | 0.530 |
Why?
|
Constipation | 1 | 2016 | 63 | 0.530 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 413 | 0.520 |
Why?
|
Respiration, Artificial | 1 | 2018 | 334 | 0.520 |
Why?
|
Counseling | 1 | 2016 | 145 | 0.510 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 41 | 0.510 |
Why?
|
Medication Adherence | 1 | 2016 | 129 | 0.510 |
Why?
|
Urinary Incontinence, Stress | 1 | 2017 | 192 | 0.510 |
Why?
|
Residence Characteristics | 1 | 2016 | 197 | 0.500 |
Why?
|
Urinary Incontinence | 1 | 2017 | 206 | 0.500 |
Why?
|
Quality Improvement | 3 | 2015 | 428 | 0.490 |
Why?
|
Bariatric Surgery | 1 | 2017 | 194 | 0.490 |
Why?
|
Seizures | 1 | 2016 | 295 | 0.480 |
Why?
|
Physicians | 2 | 2020 | 673 | 0.480 |
Why?
|
Carotid Stenosis | 1 | 2015 | 112 | 0.470 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2015 | 112 | 0.470 |
Why?
|
Recurrence | 1 | 2016 | 1139 | 0.470 |
Why?
|
Adult | 18 | 2024 | 25640 | 0.460 |
Why?
|
Sepsis | 1 | 2017 | 306 | 0.460 |
Why?
|
Quality of Health Care | 3 | 2013 | 380 | 0.450 |
Why?
|
Antihypertensive Agents | 1 | 2017 | 521 | 0.450 |
Why?
|
Vaccination | 1 | 2014 | 254 | 0.440 |
Why?
|
Hepatitis C | 1 | 2015 | 208 | 0.440 |
Why?
|
Lung | 1 | 2018 | 1170 | 0.430 |
Why?
|
Disease Management | 5 | 2019 | 327 | 0.430 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 408 | 0.420 |
Why?
|
Extraterrestrial Environment | 1 | 2011 | 1 | 0.420 |
Why?
|
Meteoroids | 1 | 2011 | 1 | 0.420 |
Why?
|
Stars, Celestial | 1 | 2011 | 1 | 0.420 |
Why?
|
Hypertension | 2 | 2017 | 1141 | 0.390 |
Why?
|
Health Care Reform | 1 | 2011 | 90 | 0.350 |
Why?
|
Stroke | 2 | 2018 | 965 | 0.350 |
Why?
|
Female | 26 | 2021 | 44507 | 0.340 |
Why?
|
United States | 8 | 2024 | 6665 | 0.310 |
Why?
|
Cardiovascular Diseases | 3 | 2016 | 827 | 0.310 |
Why?
|
Health Maintenance Organizations | 3 | 1999 | 20 | 0.300 |
Why?
|
Healthcare Disparities | 3 | 2010 | 370 | 0.300 |
Why?
|
Attitude to Health | 2 | 1999 | 220 | 0.290 |
Why?
|
Risk | 3 | 2024 | 674 | 0.280 |
Why?
|
Male | 20 | 2021 | 40956 | 0.240 |
Why?
|
Vaginal Smears | 2 | 2021 | 68 | 0.240 |
Why?
|
Heart Valve Diseases | 2 | 2024 | 109 | 0.240 |
Why?
|
Antirheumatic Agents | 1 | 2024 | 54 | 0.240 |
Why?
|
Aortic Diseases | 1 | 2024 | 100 | 0.230 |
Why?
|
Sex Factors | 4 | 2021 | 1054 | 0.220 |
Why?
|
Coronary Artery Disease | 3 | 2013 | 350 | 0.220 |
Why?
|
Arthritis, Rheumatoid | 1 | 2024 | 166 | 0.220 |
Why?
|
Acute-On-Chronic Liver Failure | 1 | 2021 | 5 | 0.210 |
Why?
|
Lung Neoplasms | 1 | 2014 | 2261 | 0.210 |
Why?
|
Death, Sudden, Cardiac | 2 | 2016 | 45 | 0.210 |
Why?
|
Middle Aged | 15 | 2020 | 25017 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 864 | 0.200 |
Why?
|
Gout Suppressants | 1 | 2021 | 36 | 0.200 |
Why?
|
Liver Failure, Acute | 1 | 2021 | 38 | 0.200 |
Why?
|
Physicians, Primary Care | 3 | 2012 | 104 | 0.200 |
Why?
|
Postmenopause | 1 | 2021 | 98 | 0.200 |
Why?
|
Gout | 1 | 2021 | 76 | 0.200 |
Why?
|
Risk Assessment | 4 | 2018 | 2261 | 0.200 |
Why?
|
Iron | 1 | 2021 | 164 | 0.190 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2021 | 106 | 0.190 |
Why?
|
Smoking | 2 | 2015 | 609 | 0.190 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2021 | 153 | 0.190 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2020 | 8 | 0.180 |
Why?
|
Morphinans | 1 | 2019 | 4 | 0.180 |
Why?
|
Uterine Diseases | 1 | 2020 | 19 | 0.180 |
Why?
|
Streptococcus pneumoniae | 1 | 2020 | 48 | 0.180 |
Why?
|
Bone Marrow | 1 | 2021 | 435 | 0.180 |
Why?
|
Drug Resistance, Bacterial | 1 | 2020 | 71 | 0.180 |
Why?
|
Acute Disease | 2 | 2021 | 826 | 0.180 |
Why?
|
Community-Acquired Infections | 1 | 2020 | 63 | 0.180 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 275 | 0.170 |
Why?
|
Prescription Drugs | 1 | 2019 | 36 | 0.170 |
Why?
|
Guideline Adherence | 3 | 2021 | 223 | 0.170 |
Why?
|
Hypoglycemic Agents | 2 | 2018 | 378 | 0.170 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 243 | 0.160 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2018 | 31 | 0.160 |
Why?
|
Urban Health Services | 2 | 2011 | 45 | 0.160 |
Why?
|
Naltrexone | 1 | 2019 | 135 | 0.160 |
Why?
|
Premenopause | 1 | 2018 | 54 | 0.160 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 154 | 0.160 |
Why?
|
Pregnancy | 2 | 2016 | 2893 | 0.160 |
Why?
|
Follicle Stimulating Hormone | 1 | 2018 | 147 | 0.160 |
Why?
|
Informed Consent By Minors | 1 | 2017 | 2 | 0.160 |
Why?
|
Luteinizing Hormone | 1 | 2018 | 167 | 0.160 |
Why?
|
Sex Reassignment Procedures | 1 | 2017 | 4 | 0.160 |
Why?
|
Evidence-Based Practice | 1 | 2018 | 45 | 0.160 |
Why?
|
Antidiarrheals | 1 | 2017 | 14 | 0.160 |
Why?
|
Drug Prescriptions | 1 | 2019 | 141 | 0.150 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 894 | 0.150 |
Why?
|
Dyslipidemias | 1 | 2018 | 109 | 0.150 |
Why?
|
Mental Competency | 1 | 2017 | 49 | 0.150 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 363 | 0.150 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2017 | 103 | 0.150 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 193 | 0.150 |
Why?
|
Weight Loss | 1 | 2018 | 229 | 0.150 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 1990 | 0.150 |
Why?
|
Observational Studies as Topic | 1 | 2017 | 48 | 0.150 |
Why?
|
Long QT Syndrome | 1 | 2016 | 34 | 0.140 |
Why?
|
Recovery of Function | 1 | 2018 | 272 | 0.140 |
Why?
|
Probiotics | 1 | 2017 | 81 | 0.140 |
Why?
|
Social Perception | 1 | 1997 | 95 | 0.140 |
Why?
|
Liver Cirrhosis | 1 | 2018 | 297 | 0.140 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2018 | 203 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2017 | 155 | 0.130 |
Why?
|
Age Factors | 6 | 2021 | 1849 | 0.130 |
Why?
|
Physician's Role | 1 | 1997 | 179 | 0.130 |
Why?
|
Cause of Death | 1 | 2016 | 277 | 0.130 |
Why?
|
Aged | 9 | 2016 | 18402 | 0.130 |
Why?
|
Pharmacogenetics | 1 | 2019 | 434 | 0.130 |
Why?
|
Referral and Consultation | 1 | 2017 | 326 | 0.130 |
Why?
|
Blood Glucose | 1 | 2018 | 873 | 0.120 |
Why?
|
Pressure Ulcer | 2 | 2013 | 42 | 0.120 |
Why?
|
Life Expectancy | 1 | 2014 | 86 | 0.120 |
Why?
|
Advisory Committees | 1 | 2014 | 90 | 0.120 |
Why?
|
Documentation | 2 | 2013 | 98 | 0.120 |
Why?
|
Aging | 1 | 1999 | 691 | 0.120 |
Why?
|
Hepacivirus | 1 | 2015 | 159 | 0.120 |
Why?
|
Critical Care | 1 | 2017 | 370 | 0.120 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 1565 | 0.120 |
Why?
|
Hospitalization | 3 | 2016 | 848 | 0.110 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2013 | 66 | 0.110 |
Why?
|
Teaching | 2 | 2011 | 147 | 0.110 |
Why?
|
Checklist | 1 | 2013 | 57 | 0.110 |
Why?
|
Epilepsy | 1 | 2016 | 395 | 0.110 |
Why?
|
Ultrasonography | 1 | 2015 | 695 | 0.110 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 746 | 0.110 |
Why?
|
Carbon Compounds, Inorganic | 1 | 2011 | 1 | 0.110 |
Why?
|
Silicon Compounds | 1 | 2011 | 1 | 0.110 |
Why?
|
Communication | 2 | 2019 | 440 | 0.110 |
Why?
|
Genetic Testing | 1 | 2016 | 535 | 0.110 |
Why?
|
Diamond | 1 | 2011 | 3 | 0.110 |
Why?
|
Nitrogen Isotopes | 1 | 2011 | 14 | 0.110 |
Why?
|
Blood Pressure | 1 | 2017 | 1143 | 0.110 |
Why?
|
Graphite | 1 | 2011 | 12 | 0.100 |
Why?
|
Carbon Isotopes | 1 | 2011 | 76 | 0.100 |
Why?
|
Societies, Medical | 1 | 2016 | 572 | 0.100 |
Why?
|
Education | 1 | 2011 | 58 | 0.100 |
Why?
|
Primary Health Care | 3 | 2011 | 339 | 0.100 |
Why?
|
Patients | 1 | 2012 | 100 | 0.100 |
Why?
|
Models, Chemical | 1 | 2011 | 178 | 0.100 |
Why?
|
Patient Handoff | 1 | 2012 | 93 | 0.100 |
Why?
|
Medical Informatics Applications | 1 | 2010 | 9 | 0.100 |
Why?
|
Risk Factors | 3 | 2016 | 5416 | 0.090 |
Why?
|
Patient Transfer | 1 | 2011 | 91 | 0.090 |
Why?
|
Cost of Illness | 1 | 2011 | 150 | 0.090 |
Why?
|
Awareness | 1 | 2010 | 93 | 0.090 |
Why?
|
Insurance, Health | 1 | 2011 | 160 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2011 | 169 | 0.090 |
Why?
|
Sigmoidoscopy | 1 | 1989 | 36 | 0.090 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 62 | 0.090 |
Why?
|
Minority Groups | 2 | 2007 | 137 | 0.080 |
Why?
|
Telemedicine | 1 | 2011 | 169 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2010 | 207 | 0.080 |
Why?
|
Albuminuria | 1 | 2010 | 153 | 0.080 |
Why?
|
Retrospective Studies | 4 | 2016 | 8475 | 0.080 |
Why?
|
Hospitalists | 1 | 2010 | 131 | 0.080 |
Why?
|
Inpatients | 1 | 2011 | 297 | 0.080 |
Why?
|
Mandatory Reporting | 1 | 2007 | 7 | 0.080 |
Why?
|
Adolescent | 2 | 2017 | 8979 | 0.080 |
Why?
|
Patient Discharge | 1 | 2010 | 300 | 0.080 |
Why?
|
Reimbursement, Incentive | 1 | 2007 | 37 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2010 | 240 | 0.070 |
Why?
|
Program Development | 1 | 2007 | 124 | 0.070 |
Why?
|
Postoperative Complications | 1 | 2017 | 2207 | 0.070 |
Why?
|
Hospitals, Teaching | 3 | 2011 | 115 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2007 | 220 | 0.070 |
Why?
|
Primary Prevention | 1 | 2006 | 85 | 0.070 |
Why?
|
Defibrillators, Implantable | 1 | 2006 | 129 | 0.060 |
Why?
|
Intensive Care Units | 2 | 2021 | 373 | 0.060 |
Why?
|
Prospective Studies | 4 | 2016 | 4210 | 0.060 |
Why?
|
Aged, 80 and over | 1 | 2014 | 6501 | 0.060 |
Why?
|
Analgesics | 2 | 2021 | 119 | 0.060 |
Why?
|
American Heart Association | 1 | 2024 | 92 | 0.060 |
Why?
|
Age of Onset | 1 | 2024 | 310 | 0.060 |
Why?
|
Internship and Residency | 1 | 2012 | 1004 | 0.060 |
Why?
|
Hydroxyethyl Starch Derivatives | 1 | 2021 | 6 | 0.050 |
Why?
|
Uricosuric Agents | 1 | 2021 | 11 | 0.050 |
Why?
|
American Cancer Society | 1 | 2021 | 13 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 5209 | 0.050 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2021 | 27 | 0.050 |
Why?
|
Intimate Partner Violence | 1 | 2021 | 20 | 0.050 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 53 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 1989 | 938 | 0.050 |
Why?
|
Norepinephrine | 1 | 2021 | 167 | 0.050 |
Why?
|
Uric Acid | 1 | 2021 | 139 | 0.050 |
Why?
|
Chicago | 3 | 1997 | 1379 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2010 | 999 | 0.050 |
Why?
|
Logistic Models | 2 | 2011 | 1185 | 0.050 |
Why?
|
Manipulation, Orthopedic | 1 | 1999 | 5 | 0.050 |
Why?
|
Low Back Pain | 1 | 1999 | 40 | 0.040 |
Why?
|
Drug Recalls | 1 | 2019 | 13 | 0.040 |
Why?
|
Plants, Toxic | 1 | 1999 | 26 | 0.040 |
Why?
|
Critical Illness | 1 | 2021 | 294 | 0.040 |
Why?
|
Electronic Health Records | 2 | 2013 | 319 | 0.040 |
Why?
|
Liver | 1 | 2023 | 1229 | 0.040 |
Why?
|
Pharmacogenomic Testing | 1 | 2019 | 97 | 0.040 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 141 | 0.040 |
Why?
|
Papanicolaou Test | 1 | 1997 | 38 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2024 | 7988 | 0.040 |
Why?
|
Self Disclosure | 1 | 1997 | 31 | 0.040 |
Why?
|
Research | 1 | 2019 | 253 | 0.040 |
Why?
|
Personality Inventory | 1 | 1997 | 108 | 0.040 |
Why?
|
Health Promotion | 1 | 1999 | 160 | 0.040 |
Why?
|
Incidence | 2 | 2016 | 1576 | 0.040 |
Why?
|
New Zealand | 1 | 2016 | 22 | 0.040 |
Why?
|
Health Personnel | 1 | 1999 | 202 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 1997 | 364 | 0.040 |
Why?
|
Australia | 1 | 2016 | 99 | 0.040 |
Why?
|
Health Care Surveys | 1 | 1997 | 278 | 0.040 |
Why?
|
Mental Recall | 1 | 1997 | 159 | 0.030 |
Why?
|
Autopsy | 1 | 2016 | 116 | 0.030 |
Why?
|
Age Distribution | 1 | 2016 | 204 | 0.030 |
Why?
|
Analysis of Variance | 1 | 1997 | 912 | 0.030 |
Why?
|
Precision Medicine | 1 | 2019 | 395 | 0.030 |
Why?
|
Electrocardiography | 1 | 2016 | 478 | 0.030 |
Why?
|
Pneumococcal Vaccines | 1 | 2013 | 28 | 0.030 |
Why?
|
Catheter-Related Infections | 1 | 2013 | 23 | 0.030 |
Why?
|
Cognition | 1 | 1997 | 570 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2010 | 454 | 0.030 |
Why?
|
Prevalence | 1 | 2016 | 1239 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2013 | 232 | 0.030 |
Why?
|
Global Health | 1 | 2013 | 193 | 0.030 |
Why?
|
Videoconferencing | 1 | 2011 | 16 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 1997 | 1621 | 0.030 |
Why?
|
Self-Assessment | 1 | 2011 | 47 | 0.030 |
Why?
|
Models, Educational | 1 | 2011 | 50 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2013 | 144 | 0.030 |
Why?
|
Bedding and Linens | 1 | 2011 | 12 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2011 | 30 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 860 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 857 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2011 | 54 | 0.020 |
Why?
|
Patient Preference | 1 | 2011 | 105 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 59 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2016 | 2378 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 229 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2013 | 243 | 0.020 |
Why?
|
Frail Elderly | 1 | 2010 | 71 | 0.020 |
Why?
|
Infant | 1 | 2016 | 3045 | 0.020 |
Why?
|
Patient Participation | 1 | 2011 | 216 | 0.020 |
Why?
|
Regression Analysis | 1 | 2011 | 596 | 0.020 |
Why?
|
Perception | 1 | 2010 | 168 | 0.020 |
Why?
|
Qualitative Research | 1 | 2010 | 256 | 0.020 |
Why?
|
Child, Preschool | 1 | 2016 | 3611 | 0.020 |
Why?
|
Psychometrics | 1 | 2010 | 327 | 0.020 |
Why?
|
Internal Medicine | 1 | 2012 | 347 | 0.020 |
Why?
|
Pilot Projects | 1 | 2011 | 839 | 0.020 |
Why?
|
Surveys and Questionnaires | 2 | 2011 | 2501 | 0.020 |
Why?
|
Heart Arrest | 1 | 2011 | 265 | 0.020 |
Why?
|
Program Evaluation | 1 | 1989 | 297 | 0.020 |
Why?
|
Odds Ratio | 1 | 2010 | 678 | 0.020 |
Why?
|
Data Collection | 1 | 1989 | 372 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 2270 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1989 | 451 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2007 | 319 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2013 | 3636 | 0.020 |
Why?
|
Clinical Competence | 1 | 2011 | 751 | 0.020 |
Why?
|
Cohort Studies | 1 | 2012 | 2767 | 0.020 |
Why?
|
Child | 1 | 2016 | 6926 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1989 | 556 | 0.020 |
Why?
|
Coronary Disease | 1 | 2006 | 261 | 0.020 |
Why?
|
Medically Underserved Area | 1 | 2004 | 25 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 5974 | 0.020 |
Why?
|
Ventricular Dysfunction | 1 | 2004 | 28 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 1997 | 2887 | 0.010 |
Why?
|
Prognosis | 1 | 2011 | 3674 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2006 | 318 | 0.010 |
Why?
|
Medicare | 1 | 2006 | 406 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2004 | 751 | 0.010 |
Why?
|
Manipulation, Spinal | 1 | 1999 | 2 | 0.010 |
Why?
|
Physical Therapy Modalities | 1 | 1999 | 84 | 0.010 |
Why?
|
Echocardiography | 1 | 2004 | 911 | 0.010 |
Why?
|
Mammography | 1 | 1997 | 461 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1997 | 2705 | 0.010 |
Why?
|